LivaNova (LIVN) FCF Margin Growth (5y) (2021 - 2026)
LivaNova (LIVN) FCF Margin Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn |
| 2 | Stryker | 127.82 Bn | 124.35 Bn | 4.50 Bn |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.38 Bn | 72.84 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn |
| 6 | Dexcom | 34.44 Bn | 32.50 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.80 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 170.00 |
| Mar 31, 2026 | -324.00 |
| Dec 31, 2025 | 262.00 |
| Sep 30, 2025 | 1,814.00 |
| Jun 30, 2025 | 2,913.00 |
| Mar 31, 2025 | 5,145.00 |
| Dec 31, 2024 | 2,297.00 |
| Sep 30, 2024 | 4,107.00 |
| Jun 30, 2024 | 1,861.00 |
| Mar 31, 2024 | 272.00 |
| Dec 31, 2023 | 1,053.00 |
| Sep 30, 2023 | -1,113.00 |
| Jun 30, 2023 | -1,551.00 |
| Mar 31, 2023 | -85.00 |
| Dec 31, 2022 | 34.00 |
| Sep 30, 2022 | -143.00 |
| Jun 30, 2022 | -292.00 |
| Mar 31, 2022 | -272.00 |
| Dec 31, 2021 | -298.00 |
| Sep 30, 2021 | -210.00 |